NCT01050517View on ClinicalTrials.gov

Safety and Efficacy of Drug Combinations Against Triple Infections

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Parasitic Diseases
Interventions
DRUG

albendazole + ivermectin + praziquantel

albendazole (400 mg one dose) + ivermectin 200 microgram/kg body weight) + praziquantel (40 mg/kg)

DRUG

albendazole + ivermectin + (1 week later) praziquantel

albendazole (400 mg one dose) + ivermectin (200 microgram/kg body weight) + (1 week later) praziquantel (40 mg/kg)

Trial Locations (1)

Unknown

Vector Control Division, Kampala

All Listed Sponsors
lead

DBL -Institute for Health Research and Development

OTHER

NCT01050517 - Safety and Efficacy of Drug Combinations Against Triple Infections | Biotech Hunter | Biotech Hunter